Sorafenib in progressive castrate-resistant prostate cancer. Can we talk about a new therapeutic option?
{{output}}
Castrate-resistant prostate cancer represents a significant clinical challenge. Currently, the standard treatment for patients with castrate-resistant prostate cancer is chemotherapy, after which patients only receive symptomatic treatment. The available resul... ...
